He pretends to be a lot of things, except what he actually is - a lowly insurance analyst.
Often wrong, but never in doubt!
Latest Vaccine News
- Thread starter gwb-trading
- Start date
He pretends to be a lot of things, except what he actually is - a lowly insurance analyst.
Often wrong, but never in doubt!
Another Covid vaccine enters the European market...
Covid vaccine granted marketing authorization in Europe
https://www.labiotech.eu/trends-news/valneva-covid-vaccine-market-authorization/
Specialty vaccine company, Valneva, has been given marketing authorization in Europe for its inactivated whole-virus COVID-19 vaccine VLA2001.
This is a turnaround from the company’s situation in May of this year when the stock price was knocked down by 20% when gaining traction in the EU was proving to be a struggle. Despite authorization from the UK’s drug regulator, The European Medicines Agency (EMA) at this time declined to recommend the approval until undisclosed questions had been answered.
The EMA supports the development of medicines that address unmet medical needs and in the interest of public health can grant the conditional authorization. These are usually given to medicines on less comprehensive clinical data than what is usually required but where the benefit of immediate availability of the medicine outweighs the risk inherent in the fact additional data is still required.
Standards met
With the standards now being met and the authorization granted, VLA2001 can be used as primary vaccination in people from 18 to 50 years of age and the authorization will cover all 28 European Union Member States as well as Iceland, Liechtenstein, and Norway.
Thomas Lingelbach, chief executive officer of Valneva said: “We are extremely pleased that the EC granted full marketing authorization for VLA2001. We have shown that Valneva has the expertise to bring a vaccine all the way from bench to market. Since we began working on VLA2001, we have continued to receive messages from Europeans who are waiting for a more traditional vaccine technology.”
Lingelbach said now the company has received this full marketing authorization, it is hoped that the EC and its member states will place orders that reflect this demand.
Covid vaccine granted marketing authorization in Europe
https://www.labiotech.eu/trends-news/valneva-covid-vaccine-market-authorization/
Specialty vaccine company, Valneva, has been given marketing authorization in Europe for its inactivated whole-virus COVID-19 vaccine VLA2001.
This is a turnaround from the company’s situation in May of this year when the stock price was knocked down by 20% when gaining traction in the EU was proving to be a struggle. Despite authorization from the UK’s drug regulator, The European Medicines Agency (EMA) at this time declined to recommend the approval until undisclosed questions had been answered.
The EMA supports the development of medicines that address unmet medical needs and in the interest of public health can grant the conditional authorization. These are usually given to medicines on less comprehensive clinical data than what is usually required but where the benefit of immediate availability of the medicine outweighs the risk inherent in the fact additional data is still required.
Standards met
With the standards now being met and the authorization granted, VLA2001 can be used as primary vaccination in people from 18 to 50 years of age and the authorization will cover all 28 European Union Member States as well as Iceland, Liechtenstein, and Norway.
Thomas Lingelbach, chief executive officer of Valneva said: “We are extremely pleased that the EC granted full marketing authorization for VLA2001. We have shown that Valneva has the expertise to bring a vaccine all the way from bench to market. Since we began working on VLA2001, we have continued to receive messages from Europeans who are waiting for a more traditional vaccine technology.”
Lingelbach said now the company has received this full marketing authorization, it is hoped that the EC and its member states will place orders that reflect this demand.
Omicron specific Covid vaccines will be rolled out in the fall...
This Fall Will Be a Vaccination Reboot
For the first time, COVID vaccines are getting an update in the U.S. But Americans still need to be persuaded to take them.
https://www.theatlantic.com/health/archive/2022/06/fda-updated-covid-fall-booster/661423/
This Fall Will Be a Vaccination Reboot
For the first time, COVID vaccines are getting an update in the U.S. But Americans still need to be persuaded to take them.
https://www.theatlantic.com/health/archive/2022/06/fda-updated-covid-fall-booster/661423/
Fauci sick again.
I have lost track. Is this because he failed to get his ten required shots for last month or is he sick because he did get them?
Fauci says he is experiencing ‘rebound’ of COVID symptoms after Paxlovid treatment
https://thehill.com/policy/healthca...d-of-covid-symptoms-after-paxlovid-treatment/
I have lost track. Is this because he failed to get his ten required shots for last month or is he sick because he did get them?
Fauci says he is experiencing ‘rebound’ of COVID symptoms after Paxlovid treatment
https://thehill.com/policy/healthca...d-of-covid-symptoms-after-paxlovid-treatment/
Nothing more than the typical rebound issues associated with Paxlovid -- which bring many to question its value as a treatment. Typically during the rebound phase the person feels worse than during the initial days with Covid when taking Paxlovid. Overall however, Paxlovid does reduce the chances of serious Covid illness in those at risk due to age or comorbidities.
Yeh. If it doesn't kill ya.
I think he needs to keep up with his booster shots. Apparently 20 is/are not enough and if the wind blows, well, that could create a new variant not covered.
On the plus side, I heard that Moderna just got another YUGE tranche of money to develop more vaccines and YOU KNOW WHO FAUCI has a big financial interest in Moderna based on patents developed while he was a public employee. So although Fauxci is hurting and does not feel well, his wallet be doing fine.
Do you have any respectable mainstream sources to back up your claims about Fauci and patents. You know… considering that fact checks about Dr. Fauci personally profiting from work with drug companies have been found these type of assertions to be false.
I know that when Rand Paul asked him he schooled Rand on how he was not required to release information on all royalties but he did cite one instance where he only got a hundred dollars or so that year from one company. Them Paul asks him about all the others where the info was redacted.
Heh, crabwalk. Nothing to see there.